Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Clinical trial NCT04888338 · RECRUITING

Trial details

NCT number: NCT04888338
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Hematopoietic and Lymphoid Cell Neoplasm

Start date: 2021-04-10
Primary completion: 2026-11-14
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.